SEC Form 4 · accession 0001203311-16-000076
SEATTLE GENETICS INC /WA · SGEN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel G Welch
Director
Period of report
Mar 8, 2016
Accepted (ET)
Mar 10, 2016 · 3:16 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001060736
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 8, 2016 | M | 25,000 | $9.82 | A | 41,819 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F1,F2 | $9.82 | Mar 8, 2016 | M | 25,000 | D | — | Jun 13, 2017 | Common Stock | 25,000 | 0 | D |
Explanation of responses
- F1Amount of securities beneficially owned following the reported transaction(s) include Restricted Stock Units that are subject to vesting.
- F2Shares vested at a rate of 25% on 6/13/08 and monthly thereafter until all the shares were fully vested on 6/13/11.